SANUWAVE Health, Inc. (SNWV)
USD 30.66
(-0.03%)
USD 30.66
(-0.03%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 20.39 Million USD | 21.84% |
| 2022 | 16.74 Million USD | 28.69% |
| 2021 | 13.01 Million USD | 220.64% |
| 2020 | 4.05 Million USD | 294.42% |
| 2019 | 1.02 Million USD | -44.39% |
| 2018 | 1.85 Million USD | 150.51% |
| 2017 | 738.52 Thousand USD | -46.33% |
| 2016 | 1.37 Million USD | 42.52% |
| 2015 | 965.5 Thousand USD | 13.94% |
| 2014 | 847.36 Thousand USD | 5.92% |
| 2013 | 800.02 Thousand USD | 4.01% |
| 2012 | 769.21 Thousand USD | -4.16% |
| 2011 | 802.57 Thousand USD | 10.18% |
| 2010 | 728.44 Thousand USD | 10.25% |
| 2009 | 660.72 Thousand USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 5.78 Million USD | -17.27% |
| 2024 Q2 | 7.16 Million USD | 23.78% |
| 2023 Q2 | 4.67 Million USD | 23.84% |
| 2023 FY | 20.39 Million USD | 21.84% |
| 2023 Q3 | 4.95 Million USD | 5.95% |
| 2023 Q4 | 6.99 Million USD | 41.21% |
| 2023 Q1 | 3.77 Million USD | -31.36% |
| 2022 FY | 16.74 Million USD | 28.69% |
| 2022 Q2 | 3.88 Million USD | 21.5% |
| 2022 Q1 | 3.19 Million USD | -25.0% |
| 2022 Q3 | 4.16 Million USD | 7.32% |
| 2022 Q4 | 5.5 Million USD | 32.02% |
| 2021 Q1 | 2.11 Million USD | 13.84% |
| 2021 FY | 13.01 Million USD | 220.64% |
| 2021 Q2 | 2.9 Million USD | 37.48% |
| 2021 Q3 | 3.72 Million USD | 28.05% |
| 2021 Q4 | 4.26 Million USD | 14.36% |
| 2020 Q3 | 1.96 Million USD | 2261.19% |
| 2020 FY | 4.05 Million USD | 294.42% |
| 2020 Q1 | 148.59 Thousand USD | -55.8% |
| 2020 Q2 | 83.3 Thousand USD | -43.94% |
| 2020 Q4 | 1.85 Million USD | -5.5% |
| 2019 Q4 | 336.15 Thousand USD | 70.08% |
| 2019 FY | 1.02 Million USD | -44.39% |
| 2019 Q1 | 177.96 Thousand USD | -61.04% |
| 2019 Q2 | 316.97 Thousand USD | 78.11% |
| 2019 Q3 | 197.64 Thousand USD | -37.65% |
| 2018 Q1 | 344.27 Thousand USD | 8.83% |
| 2018 FY | 1.85 Million USD | 150.51% |
| 2018 Q4 | 456.78 Thousand USD | -23.33% |
| 2018 Q3 | 595.78 Thousand USD | 31.46% |
| 2018 Q2 | 453.21 Thousand USD | 31.64% |
| 2017 Q2 | 111.04 Thousand USD | -25.76% |
| 2017 FY | 738.52 Thousand USD | -46.33% |
| 2017 Q1 | 149.56 Thousand USD | -76.91% |
| 2017 Q4 | 316.32 Thousand USD | 95.77% |
| 2017 Q3 | 161.58 Thousand USD | 45.51% |
| 2016 Q4 | 647.68 Thousand USD | 153.34% |
| 2016 Q1 | 269.32 Thousand USD | -27.5% |
| 2016 Q3 | 255.65 Thousand USD | 25.69% |
| 2016 FY | 1.37 Million USD | 42.52% |
| 2016 Q2 | 203.4 Thousand USD | -24.48% |
| 2015 Q4 | 371.46 Thousand USD | 158.67% |
| 2015 Q1 | 210.45 Thousand USD | -11.07% |
| 2015 FY | 965.5 Thousand USD | 13.94% |
| 2015 Q3 | 143.6 Thousand USD | -40.16% |
| 2015 Q2 | 239.98 Thousand USD | 14.03% |
| 2014 Q1 | 145.09 Thousand USD | -49.92% |
| 2014 Q4 | 236.66 Thousand USD | 4.03% |
| 2014 Q3 | 227.49 Thousand USD | -4.46% |
| 2014 Q2 | 238.11 Thousand USD | 64.11% |
| 2014 FY | 847.36 Thousand USD | 5.92% |
| 2013 Q2 | 160.61 Thousand USD | -20.18% |
| 2013 Q3 | 148.42 Thousand USD | -7.59% |
| 2013 Q4 | 289.75 Thousand USD | 95.23% |
| 2013 FY | 800.02 Thousand USD | 4.01% |
| 2013 Q1 | 201.23 Thousand USD | 41.65% |
| 2012 Q1 | 238.54 Thousand USD | 5.83% |
| 2012 Q2 | 210.35 Thousand USD | -11.81% |
| 2012 Q3 | 178.25 Thousand USD | -15.26% |
| 2012 Q4 | 142.06 Thousand USD | -20.3% |
| 2012 FY | 769.21 Thousand USD | -4.16% |
| 2011 Q3 | 161.67 Thousand USD | -1.26% |
| 2011 Q4 | 225.39 Thousand USD | 39.41% |
| 2011 Q2 | 163.74 Thousand USD | -34.96% |
| 2011 FY | 802.57 Thousand USD | 10.18% |
| 2011 Q1 | 251.75 Thousand USD | 32.57% |
| 2010 Q3 | 278.21 Thousand USD | 137.33% |
| 2010 Q4 | 189.9 Thousand USD | -31.74% |
| 2010 FY | 728.44 Thousand USD | 10.25% |
| 2010 Q1 | 143.1 Thousand USD | 17.39% |
| 2010 Q2 | 117.22 Thousand USD | -18.08% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q4 | 121.9 Thousand USD | -9.55% |
| 2009 FY | 660.72 Thousand USD | 0.0% |
| 2009 Q3 | 134.77 Thousand USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 714.7 Thousand USD | -2754.033% |
| IR-Med Inc. | - USD | -Infinity% |
| Polarean Imaging plc | 890.93 Thousand USD | -2189.51% |
| Medical Supply International USA, Inc. | 2.81 Million USD | -624.004% |
| Avitar, Inc. | 3.1 Million USD | -556.68% |
| AVITA Medical, Inc. | 50.56 Million USD | 59.657% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 97.404% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | -23451.553% |
| QHSLab, Inc. | 1.4 Million USD | -1347.699% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 97.404% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | 61.229% |
| Escalon Medical Corp. | 11.98 Million USD | -70.246% |
| Aurora Spine Corporation | 14.52 Million USD | -40.478% |
| BrainsWay Ltd. | 31.78 Million USD | 35.825% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 257.39 Thousand USD | -7824.662% |
| Hamilton Thorne Ltd. | 68.45 Million USD | 70.204% |
| Vivos Inc. | 19.5 Thousand USD | -104505.128% |
| MicroPort Scientific Corporation | 950.72 Million USD | 97.854% |
| Kelyniam Global, Inc. | 2.67 Million USD | -663.296% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | -9912.861% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | -24044.217% |
| Nanomix Corporation | 15.45 Thousand USD | -131925.89% |
| Theraclion SA | 1.82 Million USD | -1019.403% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | -2983.365% |
| Positron Corporation | 734.66 Thousand USD | -2676.5% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | -1412.298% |
| Lombard Medical, Inc. | 12.16 Million USD | -67.623% |
| ALR Technologies Inc. | 7468.00 USD | -273038.725% |
| Stratec SE | 289.14 Million USD | 92.946% |
| Vycor Medical, Inc. | 1.46 Million USD | -1296.546% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | -4954.853% |
| VMS Rehab Systems, Inc. | 71.70 USD | -28448993.445% |
| Guided Therapeutics, Inc. | 98 Thousand USD | -20714.286% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | -2730.39% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | -616.911% |
| Urologix, Inc. | 14.23 Million USD | -43.295% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | -517.602% |
| SS Innovations International, Inc. | 5.87 Million USD | -246.922% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | -50672.869% |
| Smith & Nephew plc | 5.68 Billion USD | 99.641% |
| NIOX Group Plc | 46.84 Million USD | 56.458% |
| Fuse Medical, Inc. | 16.11 Million USD | -26.574% |
| Broncus Holding Corporation | 10.25 Million USD | -98.908% |
| Brain Scientific Inc. | 214.56 Thousand USD | -9406.721% |
| Pressure BioSciences, Inc. | 1.97 Million USD | -931.367% |
| Health Logic Interactive Inc. | - USD | -Infinity% |